AMC

in page functions
1 - 8 of 8 matches Page: 1 

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

29 October 2010

AMC Baseline Study

The AMC Baseline Study presents an innovative new approach to public health funding as a way of stimulating and accelerating the development and manufacture of vaccines for developing countries.

01 September 2010

Serotype Replacement Note - Prepared by the IAC

The serotype replacement issue arises from extensive use of pneumococcal conjugate vaccine, which is expected to result in some increase of disease occurence due to serotypes not in the vaccine. This raises question whether the increases could reach a point where the benefit of the vaccine is lost, or the increases will be small relative to the decline in vaccine type disease.

23 August 2010

AMC IAC eligibility determination meeting: 23 August 2010

The purpose of the meeting was to review Pfizer’s application for AMC eligibility for Prevenar 13 and determine if the candidate vaccine met the TPP for the AMC.

29 July 2010

Pneumococcal AMC Inflation Review Application Process

The process for manufacturers interested in submitting an Inflation Review Application.

16 June 2010

Remaining AMC offer amount 2010

The official formal notification of the remaining AMC Offer Amount.

16 April 2010

PneumoADIP

PneumoADIP is a small, dedicated team based at Johns Hopkins Bloomberg School of Public Health, supported by a $30 million grant from the GAVI Alliance.

16 April 2010

Minutes from AMC Eligibility Determination Meeting April 2010

Minutes from AMC Eligibility Determination Meeting held in London, UK on 16 April 2010.

31 March 2010

2010 Pneumococcal AMC Annual Report

This progress report presents an overview of the activities linked to the implementation of the pneumococcal AMC since the signature of the legal agreements on 12 June 2009 up until 31 March 2010. It was developed by the AMC Secretariat at GAVI, in collaboration with the World Bank and UNICEF’s Supply Division, and was approved by the Independent Assessment Committee on 13 April 2010.

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please




close icon

modal window here